Yang, W., Zheng, Z., Yi, P., Wang, S., Zhang, N., Ming, J., . . . Guo, H. (2020). LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling. Front Oncol.
Citación estilo ChicagoYang, Wen, Zhikun Zheng, Pengfei Yi, Shi Wang, Ning Zhang, Jie Ming, Jie Tan, y Hui Guo. "LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling." Front Oncol 2020.
Cita MLAYang, Wen, et al. "LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling." Front Oncol 2020.
Precaución: Estas citas no son 100% exactas.